Federico Antillon Klussmann
Overview
Explore the profile of Federico Antillon Klussmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Major A, Palese M, Ermis E, James A, Villarroel M, Klussmann F, et al.
JCO Glob Oncol
. 2022 Feb;
8:e2100266.
PMID: 35157510
Purpose: The global pediatric oncology clinical research landscape, particularly in Central and South America, Africa, and Asia, which bear the highest burden of global childhood cancer cases, is less characterized...
2.
Suiter C, Moriyama T, Matreyek K, Yang W, Scaletti E, Nishii R, et al.
Proc Natl Acad Sci U S A
. 2020 Feb;
117(10):5394-5401.
PMID: 32094176
As a prototype of genomics-guided precision medicine, individualized thiopurine dosing based on pharmacogenetics is a highly effective way to mitigate hematopoietic toxicity of this class of drugs. Recently, deficiency was...
3.
Denburg A, Cuadrado C, Alexis C, Klussmann F, Zamora J, Bodkyn C, et al.
Lancet Oncol
. 2017 Jun;
18(6):709-711.
PMID: 28593842
No abstract available.
4.
Moriyama T, Nishii R, Perez-Andreu V, Yang W, Klussmann F, Zhao X, et al.
Nat Genet
. 2016 Feb;
48(4):367-73.
PMID: 26878724
Widely used as anticancer and immunosuppressive agents, thiopurines have narrow therapeutic indices owing to frequent toxicities, partly explained by TPMT genetic polymorphisms. Recent studies identified germline NUDT15 variation as another...
5.
Barr R, Klussmann F, Baez F, Bonilla M, Moreno B, Navarrete M, et al.
Pediatr Blood Cancer
. 2013 Dec;
61(2):345-54.
PMID: 24376230
Bridging the survival gap for children with cancer, between those (the great majority) in low and middle income countries (LMIC) and their economically advantaged counterparts, is a challenge that has...
6.
Perez-Andreu V, Roberts K, Harvey R, Yang W, Cheng C, Pei D, et al.
Nat Genet
. 2013 Oct;
45(12):1494-8.
PMID: 24141364
Recent genomic profiling of childhood acute lymphoblastic leukemia (ALL) identified a high-risk subtype with an expression signature resembling that of Philadelphia chromosome-positive ALL and poor prognosis (Ph-like ALL). However, the...
7.
Patino-Garcia A, Pineiro E, Diez M, Iturriagagoitia L, Klussmann F, Sierrasesumaga Ariznabarreta L
J Pediatr Hematol Oncol
. 2003 May;
25(5):362-7.
PMID: 12759621
Purpose: To analyze the genetic and epigenetic alterations affecting the RB1, TP53, p16INK4, and p21WAF1 tumor suppressor genes, loss of heterozygosity (LOH) at 3q and 18q, and the clinical variables...